Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design.
Saved in:
| Title: | Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design. |
|---|---|
| Authors: | Brookhart MA; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.; Target RWE, Durham, North Carolina, USA., Mayne TJ; Intercept Pharmaceuticals, Morristown, New Jersey, USA., Coombs C; Real World Evidence, Syneos Health, North Carolina, USA., Breskin A; Target RWE, Durham, North Carolina, USA., Ness E; Intercept Pharmaceuticals, Morristown, New Jersey, USA., Bessonova L; Intercept Pharmaceuticals, Morristown, New Jersey, USA., Chu YJ; Intercept Pharmaceuticals, Morristown, New Jersey, USA., Li J; Intercept Pharmaceuticals, Morristown, New Jersey, USA., Fried MW; Target RWE, Durham, North Carolina, USA., Hansen BE; Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Toronto Centre for Liver Disease and TGHRI, University Health Network, Toronto, Ontario, Canada., Kowdley KV; Liver Institute Northwest and Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA., Jones D; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Mells G; Department of Hepatology, Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK., Trivedi PJ; Department of Immunology and Immunotherapy, National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK., Hiu S; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Kareithi DN; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Wason J; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK., Smith R; Department of Hepatology, Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Seeger JD; Optum Epidemiology, Boston, Massachusetts, USA., Hirschfield GM; Toronto Centre for Liver Disease and TGHRI, University Health Network, Toronto, Ontario, Canada. |
| Source: | Hepatology (Baltimore, Md.) [Hepatology] 2025 Jun 01; Vol. 81 (6), pp. 1647-1659. Date of Electronic Publication: 2025 Jan 03. |
| Publication Type: | Journal Article; Pragmatic Clinical Trial |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 39630028 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Brookhart+MA%22">Brookhart MA</searchLink>; Department of Population Health Sciences, Duke University, Durham, North Carolina, USA.; Target RWE, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Mayne+TJ%22">Mayne TJ</searchLink>; Intercept Pharmaceuticals, Morristown, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Coombs+C%22">Coombs C</searchLink>; Real World Evidence, Syneos Health, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Breskin+A%22">Breskin A</searchLink>; Target RWE, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Ness+E%22">Ness E</searchLink>; Intercept Pharmaceuticals, Morristown, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Bessonova+L%22">Bessonova L</searchLink>; Intercept Pharmaceuticals, Morristown, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Chu+YJ%22">Chu YJ</searchLink>; Intercept Pharmaceuticals, Morristown, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Li+J%22">Li J</searchLink>; Intercept Pharmaceuticals, Morristown, New Jersey, USA.<br /><searchLink fieldCode="AU" term="%22Fried+MW%22">Fried MW</searchLink>; Target RWE, Durham, North Carolina, USA.<br /><searchLink fieldCode="AU" term="%22Hansen+BE%22">Hansen BE</searchLink>; Department of Epidemiology and Biostatistics, Erasmus MC, Rotterdam, The Netherlands.; Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.; Toronto Centre for Liver Disease and TGHRI, University Health Network, Toronto, Ontario, Canada.<br /><searchLink fieldCode="AU" term="%22Kowdley+KV%22">Kowdley KV</searchLink>; Liver Institute Northwest and Elson S. Floyd College of Medicine, Washington State University, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Jones+D%22">Jones D</searchLink>; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Mells+G%22">Mells G</searchLink>; Department of Hepatology, Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.; Academic Department of Medical Genetics, University of Cambridge, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Trivedi+PJ%22">Trivedi PJ</searchLink>; Department of Immunology and Immunotherapy, National Institute for Health and Care Research (NIHR) Birmingham Biomedical Research Centre, Centre for Liver and Gastrointestinal Research, Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.<br /><searchLink fieldCode="AU" term="%22Hiu+S%22">Hiu S</searchLink>; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Kareithi+DN%22">Kareithi DN</searchLink>; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Wason+J%22">Wason J</searchLink>; Population Health Sciences Institute, Newcastle University, Newcastle upon Tyne, UK.<br /><searchLink fieldCode="AU" term="%22Smith+R%22">Smith R</searchLink>; Department of Hepatology, Cambridge Liver Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK.<br /><searchLink fieldCode="AU" term="%22Seeger+JD%22">Seeger JD</searchLink>; Optum Epidemiology, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Hirschfield+GM%22">Hirschfield GM</searchLink>; Toronto Centre for Liver Disease and TGHRI, University Health Network, Toronto, Ontario, Canada. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228302946%22">Hepatology (Baltimore, Md.)</searchLink> [Hepatology] 2025 Jun 01; Vol. 81 (6), pp. 1647-1659. <i>Date of Electronic Publication: </i>2025 Jan 03. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Pragmatic Clinical Trial – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8302946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-3350 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202709139%22">02709139 </searchLink><i>NLM ISO Abbreviation: </i>Hepatology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39630028 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HEP.0000000000001174 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 1647 Titles: – TitleFull: Hepatic real-world outcomes with obeticholic acid in primary biliary cholangitis (HEROES): A trial emulation study design. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Brookhart MA – PersonEntity: Name: NameFull: Mayne TJ – PersonEntity: Name: NameFull: Coombs C – PersonEntity: Name: NameFull: Breskin A – PersonEntity: Name: NameFull: Ness E – PersonEntity: Name: NameFull: Bessonova L – PersonEntity: Name: NameFull: Chu YJ – PersonEntity: Name: NameFull: Li J – PersonEntity: Name: NameFull: Fried MW – PersonEntity: Name: NameFull: Hansen BE – PersonEntity: Name: NameFull: Kowdley KV – PersonEntity: Name: NameFull: Jones D – PersonEntity: Name: NameFull: Mells G – PersonEntity: Name: NameFull: Trivedi PJ – PersonEntity: Name: NameFull: Hiu S – PersonEntity: Name: NameFull: Kareithi DN – PersonEntity: Name: NameFull: Wason J – PersonEntity: Name: NameFull: Smith R – PersonEntity: Name: NameFull: Seeger JD – PersonEntity: Name: NameFull: Hirschfield GM IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 06 Text: 2025 Jun 01 Type: published Y: 2025 Identifiers: – Type: issn-electronic Value: 1527-3350 Numbering: – Type: volume Value: 81 – Type: issue Value: 6 Titles: – TitleFull: Hepatology (Baltimore, Md.) Type: main |
| ResultId | 1 |